Raveneur Investment Group Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$11.9M |
| 2 |
NFX
Newfield Exploration
NFX
|
+$11.4M |
| 3 |
CPE
Callon Petroleum Company
CPE
|
+$10.8M |
| 4 |
Lowe's Companies
LOW
|
+$8.83M |
| 5 |
Boston Scientific
BSX
|
+$4.53M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$19.5M |
| 2 |
Synchrony
SYF
|
+$16.2M |
| 3 |
Kroger
KR
|
+$12.7M |
| 4 |
TWX
Time Warner Inc
TWX
|
+$8.6M |
| 5 |
Charter Communications
CHTR
|
+$8.57M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.54% |
| 2 | Consumer Staples | 9.8% |
| 3 | Consumer Discretionary | 8.17% |
| 4 | Energy | 7.97% |
| 5 | Industrials | 6.31% |
Similar funds
Raveneur Investment Group's Q2 2016 Portfolio in Review
As of Q2 2016, Raveneur Investment Group held 38 positions worth $364M, down 31% from $529M the previous quarter. Its ten largest holdings account for 70% of the portfolio.
Raveneur Investment Group withdrew a net $182M in Q2 2016, closing 18 positions and reducing 3 holdings. Its most notable exit was Elevance Health, an estimated $19.5M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 8.9% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.
Against the trend, Raveneur Investment Group opened a new position in Cigna worth $11.5M.
- Raveneur Investment Group's largest Q2 2016 buy was Cigna: 90,000 shares worth $11.5M.
- Raveneur Investment Group added most to Lowe's Companies in Q2 2016, an estimated $8.83M increase.
- Raveneur Investment Group's biggest Q2 2016 reduction was Allegion, cutting an estimated $6.17M.
- Raveneur Investment Group fully exited Elevance Health in Q2 2016, selling an estimated $19.5M.
- Raveneur Investment Group's ten largest holdings make up 70% of its $364M portfolio in Q2 2016.
- Raveneur Investment Group opened 8 new positions and closed 18 in Q2 2016.
- Raveneur Investment Group's portfolio value fell 31% quarter-over-quarter to $364M.
Based on Raveneur Investment Group's 13F filing for Q2 2016, filed 12 Aug 2016.